Bacterial vaginosis is more common in the weeks and months after giving birth than it is during pregnancy, driven largely by a dramatic postpartum reshuffling of vaginal bacteria. In one study of women in Bangladesh, the prevalence of BV rose from about 8 percent in early pregnancy to roughly 10 percent at three months postpartum, with borderline cases nearly doubling over the same period. The shift is not random or mysterious; childbirth itself disrupts the microbial environment that keeps BV-associated organisms in check, and the recovery process is slower and less complete than most people expect.
Why BV Becomes More Likely After Delivery
During pregnancy, rising estrogen levels encourage vaginal tissue to produce more glycogen, which feeds Lactobacillus bacteria. These lactobacilli produce lactic acid and keep the vaginal pH low, creating an environment that discourages the overgrowth of organisms like Gardnerella vaginalis and Prevotella. After delivery, estrogen drops sharply, especially if you are breastfeeding, and the glycogen supply falls with it. The lactobacilli lose their fuel, their numbers decline, and the door opens for a broader mix of bacteria to move in.
Metagenomic studies confirm just how stark the change is. In one analysis comparing women of childbearing age, postpartum women, and postmenopausal women, Lactobacillus dominance disappeared in the postpartum group. Diversity increased sharply, and the proportions of Atopobium vaginae, Gardnerella vaginalis, Prevotella, and Escherichia coli all climbed. Both Lactobacillus crispatus and Lactobacillus iners, the two species most associated with a healthy vaginal environment, were significantly lower in postpartum women than in non-pregnant women of the same age range.1PubMed Central. Analysis of vaginal microbiota during postpartum and postmenopausal periods based on metagenomics
A separate study tracking women from before pregnancy through the postpartum period found that the urogenital microbiome underwent a “massive loss of Lactobacillus,” shifting the majority of participants from a Lactobacillus-dominated community state to a more diverse, less stable one. Before delivery, about 40 percent of women had vaginal communities dominated by L. crispatus; by one month postpartum, 85 percent had shifted to a mixed community type that is associated with higher pH and greater susceptibility to BV.2PubMed Central. The dynamics of the female microbiome: unveiling abrupt changes of microbial domains across body sites from prepartum to postpartum phases
Physical trauma from delivery adds another layer. Whether vaginal or cesarean, birth involves tissue disruption, blood loss, and often lacerations or incisions. These create an environment where the normal mucosal defenses are weakened. Lochia, the postpartum vaginal discharge that lasts several weeks, changes the local chemistry further. Together, the hormonal crash and the physical recovery create a window in which the vaginal ecosystem is genuinely vulnerable.
What the Numbers Look Like
Estimates of postpartum BV prevalence vary depending on how it is measured and when, but the trend is consistent: rates go up after birth. In a cohort study of women in rural Bangladesh, BV diagnosed by Nugent scoring was present in 7.6 percent of women during early pregnancy and 10.4 percent at three months postpartum. When borderline scores were included, the postpartum rate climbed to about 19 percent, nearly double the early-pregnancy figure of 12 percent.3PubMed Central. Factors associated with Nugent-bacterial vaginosis in pregnancy and postpartum among women in rural northwestern Bangladesh That jump in borderline cases matters because those women may be asymptomatic but are in a transitional state that could easily tip toward full BV.
These numbers come from a specific population, and global estimates are hard to pin down because BV prevalence varies by ethnicity, geography, and sexual behavior. Studies in different countries report different baseline rates. But the upward postpartum trend appears across populations, consistent with the hormonal and mechanical forces at work.
Recognizing Postpartum BV
Spotting BV after birth is trickier than it sounds, because the normal postpartum body already produces unfamiliar discharge and odors. Lochia transitions from bright red to pink to white or yellowish over four to six weeks, and this overlapping timeline makes it easy to dismiss BV symptoms as just part of recovery.
The hallmarks of BV are the same postpartum as at any other time: a thin, grayish-white discharge with a fishy smell that tends to be stronger after sex or during menstruation. The smell is often what prompts a visit to a provider, since the discharge alone can be confused with normal lochia. There is usually no itching or burning, which is one of the things that distinguishes BV from a yeast infection. If you are experiencing itching alongside the discharge, that points more toward candidiasis, which is also common postpartum but requires different treatment.
The tricky part is that many postpartum women with BV are asymptomatic. In the Bangladesh cohort mentioned above, diagnosis relied on Nugent scoring of vaginal swabs rather than symptoms, meaning a substantial number of those positive cases would not have noticed anything wrong. This is one of the reasons postpartum BV often goes untreated and can contribute to downstream complications.
Postpartum Endometritis and Other Complications
BV after birth is not just a nuisance. One of its most clinically significant consequences is endometritis, an infection of the uterine lining that causes fever, pelvic pain, and foul-smelling discharge in the days or weeks following delivery. BV has been identified as an independent risk factor for endometritis after cesarean delivery, with one study finding that women with BV were roughly six times more likely to develop the infection. That association held even after adjusting for age, duration of labor, and how long membranes had been ruptured.4PubMed. Bacterial vaginosis as a risk factor for post-cesarean endometritis
A separate study of women diagnosed with BV in early pregnancy found that those women faced more than three times the risk of developing postpartum endometritis, suggesting the problem is not limited to the immediate peripartum period.5PubMed. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis The bacteria associated with BV, particularly Gardnerella and anaerobic species, can ascend through the cervix into the uterus, especially when the cervix is still dilated or the uterine lining has not fully healed.
Beyond endometritis, the disrupted microbial environment after birth is linked to increased local and systemic inflammation. The shift toward pathogen-enriched vaginal communities, combined with impaired epithelial barrier function, raises the risk of puerperal infections more broadly.6Journal of Pain Research. Postpartum Pain and Vaginal-Gut Microbiota Interactions: An Integrative Narrative Review with Implications for Maternal Recovery and Pain Modulation Wound infections after episiotomy or perineal tears may also be more likely when BV-associated organisms are present in high numbers, though the evidence on that specific connection is less robust.
Treating BV While Breastfeeding
Metronidazole remains the first-line treatment for BV, including in the postpartum period.7Expert Opinion on Pharmacotherapy. Metronidazole for the treatment of vaginal infections It can be given orally or as a vaginal gel. A common concern for breastfeeding mothers is whether the drug passes into breast milk and poses any risk to the infant. Metronidazole does appear in breast milk in small amounts, but current guidelines from major medical bodies consider it compatible with breastfeeding at standard doses. Some providers recommend the vaginal gel formulation to minimize systemic absorption, which in turn reduces how much reaches the milk.
Clindamycin, either oral or vaginal, is the main alternative when metronidazole is not tolerated or when a provider wants to avoid it during nursing. Vaginal clindamycin cream has the advantage of delivering the drug locally, keeping blood levels low.
One frustration with BV treatment in general is the high recurrence rate. Somewhere around half of women who are treated successfully will have a recurrence within a year, and postpartum hormonal changes may make that even more likely. Recurrence does not mean the treatment failed in a medical sense; it reflects the underlying instability of the vaginal microbiome during this period. If BV keeps coming back, a provider may discuss suppressive therapy or extended-course antibiotics, although the evidence supporting those approaches for specifically postpartum recurrence is limited.
How Long the Vaginal Microbiome Takes to Recover
One of the more surprising findings in recent research is just how slowly the vaginal ecosystem bounces back after childbirth. A longitudinal study that followed women from pregnancy through the first year postpartum found that the probability of returning to Lactobacillus dominance within one year was only about 49 percent, even though more than 86 percent of those women had been Lactobacillus-dominant before delivery. Overall microbial diversity did trend back toward pre-delivery levels by one year, but the prevalence of Lactobacillus dominance remained low.8Nature Communications. Abrupt perturbation and delayed recovery of the vaginal ecosystem following childbirth
That finding is worth sitting with. It means that for roughly half of new mothers, the vaginal microbiome has not returned to its pre-pregnancy baseline a full year after delivery. The clinical meaning of that is still being worked out. Not every woman with a non-Lactobacillus-dominant community has symptoms or problems; some women with diverse microbial profiles are perfectly healthy. But for those prone to BV, the prolonged recovery window represents an extended period of vulnerability.
The study also noted that while overall diversity fell back toward baseline over the year, the specific species that dominated the community often differed from what had been there before pregnancy. A woman who was dominated by L. crispatus before delivery might return to Lactobacillus dominance via L. iners instead, a species that is less protective and associated with more frequent transitions to BV. The postpartum microbiome, in other words, does not just pick up where it left off.
Timing of Sexual Activity and Infection Risk
There is a practical question wrapped up in all of this: when is it safe to resume sex after delivery? The traditional advice to wait six weeks is partly based on the time it takes for cervical closure and uterine healing, but vaginal microbial recovery stretches far beyond that window. Resuming intercourse while the vaginal mucosa is still healing can introduce new bacteria and raise the risk of infections, including BV.
Research on postpartum sexual activity confirms that mothers who resume intercourse in the first few months are at greater risk for infections related to vaginal lesions and abrasions from delivery. Sexual morbidity during this period is common and includes painful intercourse, vaginal dryness, difficulty reaching orgasm, and abnormal discharge.9PubMed Central. Early resumption of postpartum sexual intercourse and its associated risk factors among married postpartum women who visited public hospitals of Jimma zone, Southwest Ethiopia: A cross-sectional study These symptoms overlap with BV symptoms, which can make diagnosis even harder. If you are experiencing a fishy odor or unusual discharge after resuming sexual activity postpartum, it is worth getting tested rather than assuming the symptoms are just a normal part of recovery.
Condom use during postpartum sex may offer some protection against BV, since exposure to semen raises vaginal pH and can shift the microbial balance. This is true outside of the postpartum context as well, but the effect may be amplified when the ecosystem is already destabilized.
BV During Pregnancy and Downstream Effects on the Baby
While this article focuses on BV after birth, it is worth mentioning that BV present during pregnancy can affect both delivery outcomes and the baby. A study comparing pregnant women with and without BV found that preterm birth before 34 weeks was significantly more common in the BV group, at about 23 percent compared with 6 percent. Neonatal morbidity was also higher: babies born to mothers with BV had lower birth weights, were more likely to be admitted to intensive care, and had higher rates of respiratory distress syndrome.10PubMed Central. Maternal and fetal outcomes of pregnant women with bacterial vaginosis
Placental pathology in that study revealed that more than half of women with BV had histologic chorioamnionitis, an inflammation of the fetal membranes typically caused by ascending bacterial infection. These findings reinforce the idea that BV is not a harmless imbalance but a condition with real consequences for both mother and child. Women who had BV during pregnancy and were not treated may be at particularly high risk for complications in the postpartum period, since the same organisms are likely still present.
Racial and Ethnic Disparities in BV Risk
BV does not affect all populations equally, and this has implications for postpartum care. Research on reproductive-age women has found that around 40 percent of women identifying as Black or Hispanic had diverse, BV-associated vaginal communities, compared with roughly 10 percent of White women. Vaginal pH also differed: Black and Hispanic women had average pH values between 4.7 and 5.0, while Asian and White women averaged between 4.2 and 4.4.11JCI Insight. Social, microbial, and immune factors linking bacterial vaginosis and infectious diseases
These differences are not purely genetic. Social factors, including access to healthcare, stress, hygiene product marketing, and douching practices, play a role. But the biological reality is that a woman who enters pregnancy with a diverse, non-Lactobacillus-dominant community is starting from a different baseline, and the postpartum disruption may hit harder or take longer to recover from. Standard postpartum screening protocols often do not account for this variability, which means BV may be under-detected in the populations most affected.
There is ongoing debate about whether the Nugent scoring system and clinical criteria for BV, which were developed primarily in studies of White women, adequately capture what is “normal” versus “abnormal” across different ethnic backgrounds. A vaginal community dominated by Gardnerella in the absence of symptoms is harder to classify when the baseline community was never heavily Lactobacillus-dominated to begin with. This complicates both diagnosis and treatment decisions, especially postpartum when symptoms are already hard to disentangle from normal recovery.
Practical Steps You Can Take
There is no guaranteed way to prevent postpartum BV, but a few evidence-informed strategies can tip the odds in your favor:
- Avoid douching: Douching disrupts the vaginal microbiome at any time, and it is especially harmful when the ecosystem is already destabilized after delivery. Water alone is sufficient for external cleaning.
- Wear breathable fabrics: Cotton underwear and loose-fitting clothes reduce moisture and heat, which discourages the growth of anaerobic bacteria associated with BV.
- Discuss antibiotic stewardship: If you needed antibiotics during or after delivery for another reason, be aware that broad-spectrum antibiotics can further reduce Lactobacillus populations. This does not mean you should skip necessary antibiotics, but it is worth discussing probiotics or monitoring with your provider.
- Use condoms when resuming sex: As mentioned, semen raises vaginal pH. Barrier methods can reduce that effect during the vulnerable postpartum window.
- Seek testing if symptoms appear: The fishy odor and thin grayish discharge of BV are easy to dismiss postpartum. Early treatment reduces the risk of ascending infection.
Oral and vaginal probiotics containing Lactobacillus strains are widely marketed for vaginal health, and some women find them helpful. The scientific evidence supporting their use for BV prevention is mixed: some small trials show modest benefits, while larger reviews are less conclusive. They are unlikely to cause harm, but they should not replace antibiotic treatment when BV is already present.
When Symptoms Linger Beyond the First Year
Given the data showing that only about half of women regain Lactobacillus dominance within a year of delivery, some women will find themselves dealing with recurrent BV or persistent symptoms well beyond what they expected. This is especially common in women who are breastfeeding for an extended period, since lactation suppresses estrogen and prolongs the low-estrogen state that undermines Lactobacillus growth.
If BV keeps returning despite treatment, the approach often shifts from single courses of antibiotics to longer strategies. Some providers use a “treat and suppress” model: a full course of metronidazole followed by twice-weekly vaginal gel for several months. Others add boric acid suppositories, which lower vaginal pH and create an environment less hospitable to BV-associated organisms. Neither approach has been studied specifically in large postpartum populations, so evidence is extrapolated from general BV recurrence trials.
The broader point is that postpartum vaginal health does not always resolve on a neat timeline. If you are still dealing with unusual discharge, odor, or discomfort months after delivery, it is not something to tough out. Persistent BV-like symptoms can occasionally signal other conditions, and a provider who understands the postpartum microbiome can help distinguish between a slow return to normal and something that needs active management.